Formulation and characterization of polymeric nanoparticle of Rivastigmine for effective management of Alzheimer’s disease

Formulation and characterization of polymeric nanoparticle of Rivastigmine for effective management of Alzheimer’s disease

Memory loss or dementia is a progressive disorder, and one of its common forms is Alzheimer’s disease (AD), effecting mostly middle aged and older adults. In the present study, we developed Rivastigmine (RIV) nanoparticles using poly(lactic-co-glycolic acid) (RIV-loaded PLGA NPs) and polyvinyl alcoh...

Full description

Bibliographic Details
Main Authors: Faisal Imam, Sayantan Mukhopadhyay, Preeti Kothiyal, Samiyah Alshehri, Khalid Saad Alharbi, Muhammad Afzal, Muzaffar Iqbal, Mohammad Rashid Khan, Md. Khalid Anwer, Abdulrazaq Ahmed Hattab Alanazi, Ali Ghanem Alqahtani, Mohammed Abdullah Alhamamah
Format: Article
Language:English
Published: Elsevier 2024-05-01
Series:Saudi Pharmaceutical Journal
Subjects:
Nanoparticle
PLGA
Nanoprecipitation
Alzheimer’s disease
Cholinesterase
Online Access:http://www.sciencedirect.com/science/article/pii/S1319016424000987

Internet

http://www.sciencedirect.com/science/article/pii/S1319016424000987

Similar Items